Global
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 310.22 B |
Jan. 14, 2025 | USD 175.55 | -0.67% |
|
United States |
|
2 |
USD 213.05 B |
Jan. 14, 2025 | USD 556.99 | 0.27% |
|
United States |
|
3 |
USD 201.21 B |
Jan. 14, 2025 | USD 129.77 | -1.69% |
|
United Kingdom |
|
4 |
USD 197.34 B |
Jan. 14, 2025 | USD 98.71 | -0.26% |
|
Switzerland |
|
5 |
USD 171.63 B |
Jan. 14, 2025 | USD 237.62 | -0.94% |
|
United States |
|
6 |
USD 149.67 B |
Jan. 14, 2025 | USD 26.41 | -1.46% |
|
United States |
|
7 |
USD 143.58 B |
Jan. 14, 2025 | USD 267.10 | -1.14% |
|
United States |
|
8 |
USD 138.31 B |
Jan. 14, 2025 | USD 362.80 | 0.50% |
|
United States |
|
9 |
USD 113.41 B |
Jan. 14, 2025 | USD 91.00 | 1.18% |
|
United States |
|
10 |
USD 113.05 B |
Jan. 14, 2025 | USD 55.74 | 0.69% |
|
United States |
|
11 |
USD 106.01 B |
Jan. 14, 2025 | USD 411.66 | -0.41% |
|
United States |
|
12 |
USD 82.78 B |
Jan. 14, 2025 | USD 173.13 | 0.11% |
|
Australia |
|
13 |
USD 75.92 B |
Jan. 14, 2025 | USD 690.87 | -3.63% |
|
United States |
|
14 |
USD 74.18 B |
Jan. 14, 2025 | USD 164.41 | -1.15% |
|
United States |
|
15 |
USD 63.11 B |
Jan. 14, 2025 | USD 145.16 | 0.75% |
|
Germany |
|
16 |
USD 49.80 B |
Jan. 14, 2025 | USD 698.37 | 1.93% |
|
South Korea |
|
17 |
USD 42.45 B |
Jan. 14, 2025 | USD 588.68 | -0.80% |
|
Switzerland |
|
18 |
USD 41.85 B |
Jan. 14, 2025 | USD 60.89 | 1.60% |
|
United States |
|
19 |
USD 40.96 B |
Jan. 14, 2025 | USD 143.43 | 1.04% |
|
United States |
|
20 |
USD 40.28 B |
Jan. 14, 2025 | USD 673.61 | 1.66% |
|
Netherlands |
|
21 |
USD 38.04 B |
Jan. 14, 2025 | USD 6.04 | 3.46% |
|
China |
|
22 |
USD 37.77 B |
Jan. 14, 2025 | USD 195.15 | -0.39% |
|
Belgium |
|
23 |
USD 35.93 B |
Jan. 14, 2025 | USD 197.96 | -3.26% |
|
United States |
|
24 |
USD 31.02 B |
Jan. 14, 2025 | USD 240.51 | -6.88% |
|
United States |
|
25 |
USD 30.92 B |
Jan. 14, 2025 | USD 79.17 | -0.84% |
|
United States |
|
26 |
USD 28.37 B |
Jan. 14, 2025 | USD 116.36 | -0.45% |
|
Germany |
|
27 |
USD 27.15 B |
Jan. 14, 2025 | USD 5.05 | 2.19% |
|
China |
|
28 |
USD 26.70 B |
Jan. 14, 2025 | USD 125.83 | 1.12% |
|
South Korea |
|
29 |
USD 25.92 B |
Jan. 14, 2025 | USD 97.52 | 0.29% |
|
Switzerland |
|
30 |
USD 25.15 B |
Jan. 14, 2025 | USD 54.16 | -1.39% |
|
Denmark |
|
31 |
USD 21.93 B |
Jan. 14, 2025 | USD 14.74 | 7.67% |
|
Hong Kong |
|
32 |
USD 21.88 B |
Jan. 14, 2025 | USD 165.76 | -2.09% |
|
United States |
|
33 |
USD 21.65 B |
Jan. 14, 2025 | USD 136.48 | -5.37% |
|
United States |
|
34 |
USD 20.87 B |
Jan. 14, 2025 | USD 6.95 | 4.11% |
|
China |
|
35 |
USD 20.85 B |
Jan. 14, 2025 | USD 143.06 | -4.74% |
|
United States |
|
36 |
USD 20.26 B |
Jan. 14, 2025 | USD 208.18 | -0.28% |
|
France |
|
37 |
USD 19.85 B |
Jan. 14, 2025 | USD 20.20 | -1.60% |
|
Germany |
|
38 |
USD 19.61 B |
Jan. 14, 2025 | USD 234.50 | 0.17% |
|
United States |
|
39 |
USD 18.51 B |
Jan. 14, 2025 | USD 42.16 | 0.08% |
|
Switzerland |
|
40 |
USD 17.88 B |
Jan. 14, 2025 | USD 69.21 | 4.65% |
|
India |
|
41 |
USD 17.69 B |
Jan. 14, 2025 | USD 30.03 | 0.13% |
|
United States |
|
42 |
USD 16.28 B |
Jan. 14, 2025 | USD 364.70 | 0.50% |
|
United States |
|
43 |
USD 14.78 B |
Jan. 14, 2025 | USD 21.72 | -1.36% |
|
United States |
|
44 |
USD 14.69 B |
Jan. 14, 2025 | USD 120.73 | -1.61% |
|
United States |
|
45 |
USD 14.69 B |
Jan. 14, 2025 | USD 27.55 | -1.02% |
|
Finland |
|
46 |
USD 13.86 B |
Jan. 14, 2025 | USD 71.93 | -0.61% |
|
United States |
|
47 |
USD 13.78 B |
Jan. 14, 2025 | USD 216.88 | 1.28% |
|
Denmark |
|
48 |
USD 13.48 B |
Jan. 14, 2025 | USD 126.89 | -0.24% |
|
United States |
|
49 |
USD 13.26 B |
Jan. 14, 2025 | USD 34.46 | -1.96% |
|
United States |
|
50 |
USD 13.08 B |
Jan. 14, 2025 | USD 110.89 | -1.59% |
|
France |
The Biotechnology company with the highest Market Capitalization is AbbVie Inc. (NYSE: ABBV) at USD 310.22 B.
The Biotechnology company with the lowest Market Capitalization is Neovacs S.A. (Paris Stock Exchange: ALNEV.PA) at USD 95.91 K.
The top 10 Biotechnology companies the Global by Market Capitalization are AbbVie Inc., Thermo Fisher Scientific Inc., AstraZeneca PLC, Novartis AG, Danaher Corporation, Pfizer Inc., Amgen Inc., Stryker Corporation, Gilead Sciences, Inc. and Bristol-Myers Squibb Company.
The bottom 10 Biotechnology companies by Market Capitalization are Neovacs S.A., Ellen AB (publ), Qlife Holding AB (publ), Aptahem AB (publ), Nextgen Biomed Ltd, Ovoca Bio plc, Bluejay Diagnostics, Inc., Qlucore Ab (Publ), Scandinavian Real Heart AB (Publ) and 60 Degrees Pharmaceuticals, Inc..